PVALB and schizophrenia: Other treatments early in life, such as antipsychotics (Piontkewitz et al., 2012) or antioxidants (Cabungcal et al., 2014), have also been shown to effectively protect parvalbumin interneurons and prevent other schizophrenia-like symptoms from emerging in developmental disruption models of schizophrenia.